《人工智能在心血管疾病中的应用科学声明》解读

doi:10.12114/j.issn.1007-9572.2024.0192

中国全科医学 ›› 2024, Vol. 27 ›› Issue (35): 4353-4357.DOI: 10.12114/j.issn.1007-9572.2024.0192

所属专题：数智医疗最新文章合辑

• 指南解读 • 下一篇

《人工智能在心血管疾病中的应用科学声明》解读

周伊恒, 杨梓钰, 吕垚, 刘力滴, 沈灿, 廖晓阳, 贾禹^*()

610041　四川省成都市，四川大学华西医院全科医学中心　全科医学教研室　全科医学研究室

收稿日期:2024-04-10 修回日期:2024-07-25 出版日期:2024-12-15 发布日期:2024-09-13
通讯作者: 贾禹
周伊恒与杨梓钰为共同第一作者

作者贡献：
周伊恒、杨梓钰负责文章的构思与设计、论文撰写；吕垚、刘力滴、沈灿、廖晓阳负责对文章的修订；贾禹负责文章的质量控制及审校，对文章整体负责。
基金资助:
四川省科技厅软科学项目(2022JDR0325)

Interpretation of the Use of Artificial Intelligence in Improving Outcomes in Heart Disease：a Scientific Statement from the American Heart Association

ZHOU Yiheng, YANG Ziyu, LYU Yao, LIU Lidi, SHEN Can, LIAO Xiaoyang, JIA Yu^*()

Teaching & Research Section/General Practice Research Institute, General Practice Medical Center, West China Hospital, Sichuan University, Chengdu 610041, China

Received:2024-04-10 Revised:2024-07-25 Published:2024-12-15 Online:2024-09-13
Contact: JIA Yu
About author:
ZHOU Yiheng and YANG Ziyu are co-first authors

分享到

摘要/Abstract

摘要： 人工智能（AI）是改善卫生保健服务的新兴技术。在全球政府机构和学术部门的共同推进下，大量研究论证AI可以改进心血管疾病的诊断、治疗和预防，但其发展和应用仍存在一些限制，尚未在广泛范围内服务临床。基于此，美国心脏协会（AHA）于2024-04-02在Circulation发表了《人工智能在心血管疾病中的应用科学声明》（以下简称声明）。该声明综述了AI在心血管疾病诊断、分类和治疗中的研究进展，提出了AI应用中存在的问题以及潜在解决方案，并且构建了未来AI在心血管领域应用的框架。本文旨在对该声明进行解读，为我国AI在心血管疾病的应用和研究提供建议和方向。

关键词: 人工智能, 心血管疾病, 科学声明, 解读, 美国心脏协会

Abstract:

Artificial Intelligence (AI) is an emerging technology to improve healthcare services. With the joint promotion of government agencies and academic departments around the world, a large number of studies have demonstrated that AI can improve the diagnosis, treatment and prevention of cardiovascular disease. However, there are still some limitations in its development and application, and it has not yet been widely used in clinical practice. Based on this, the American Heart Association (AHA) published the Use of Artificial Intelligence in Improving Outcomes in Heart Disease: a Scientific Statement from the American Heart Association in Circulation on April 2, 2024. This statement reviews the research progress of AI in the diagnosis, classification and treatment of cardiovascular disease, puts forward the existing problems and potential solutions, and builds a framework for the future application of AI in the cardiovascular disease. This article aims to interpret the statement for providing advice and direction for the application and research of AI in cardiovascular disease in China.

Key words: Artificial intelligence, Cardiovascular diseases, Scientific statement, Interpretation, American Heart Association

周伊恒,杨梓钰,吕垚,等. 《人工智能在心血管疾病中的应用科学声明》解读[J]. 中国全科医学, 2024, 27(35): 4353-4357. DOI: 10.12114/j.issn.1007-9572.2024.0192.
ZHOU Yiheng,YANG Ziyu,LYU Yao, et al. Interpretation of the Use of Artificial Intelligence in Improving Outcomes in Heart Disease：a Scientific Statement from the American Heart Association[J]. Chinese General Practice, 2024, 27(35): 4353-4357. DOI: 10.12114/j.issn.1007-9572.2024.0192.

参考文献 31

[1]	CREA F. Challenges in the prevention of cardiovascular diseases：traditional and non-traditional risk factors[J]. Eur Heart J，2021，42(21):2025-2029. DOI：10.1093/eurheartj/ehab296.
[2]	VALENZUELA P L, RUILOPE L M, SANTOS-LOZANO A, et al. Exercise benefits in cardiovascular diseases：from mechanisms to clinical implementation[J]. Eur Heart J，2023，44(21):1874-1889. DOI：10.1093/eurheartj/ehad170.
[3]	LAVIE C J. Progress in cardiovascular diseases statistics 2022[J]. Prog Cardiovasc Dis，2022，73:94-95. DOI：10.1016/j.pcad.2022.08.005.
[4]	王义为，杨婷婷，朱光宇，等. 心血管数字医学的临床应用进展及展望[J]. 中国心血管病研究，2023，21(8):740-745. DOI：10.3969/j.issn.1672-5301.2023.08.012.
[5]	ARMOUNDAS A A, NARAYAN S M, ARNETT D K, et al. Use of artificial intelligence in improving outcomes in heart disease：a scientific statement from the American Heart Association[J]. Circulation，2024，149(14):e1028-1050. DOI：10.1161/CIR.0000000000001201.
[6]	WEIKERT T, FRANCONE M, ABBARA S, et al. Machine learning in cardiovascular radiology：ESCR position statement on design requirements，quality assessment，current applications，opportunities，and challenges[J]. Eur Radiol，2021，31(6):3909-3922. DOI：10.1007/s00330-020-07417-0.
[7]	VAN DEN OEVER L B, VONDER M, VAN ASSEN M, et al. Application of artificial intelligence in cardiac CT：from basics to clinical practice[J]. Eur J Radiol，2020，128:108969. DOI：10.1016/j.ejrad.2020.108969.
[8]	RAU A, SOSCHYNSKI M, TARON J, et al. Artificial intelligence and radiomics：value in cardiac MRI[J]. Radiologie，2022，62(11):947-953. DOI：10.1007/s00117-022-01060-0.
[9]	CHEN Q, PAN T, WANG Y N, et al. A coronary CT angiography radiomics model to identify vulnerable plaque and predict cardiovascular events[J]. Radiology，2023，307(2):e221693. DOI：10.1148/radiol.221693.
[10]	NARAYAN S M, WANG P J, DAUBERT J P. New concepts in sudden cardiac arrest to address an intractable epidemic：JACC state-of-the-art review[J]. J Am Coll Cardiol，2019，73(1):70-88. DOI：10.1016/j.jacc.2018.09.083.
[11]	BOLLEPALLI S C, SEVAKULA R K, AU-YEUNG W M, et al. Real-time arrhythmia detection using hybrid convolutional neural networks[J]. J Am Heart Assoc，2021，10(23):e023222. DOI：10.1161/JAHA.121.023222.
[12]	ATTIA Z I, NOSEWORTHY P A, LOPEZ-JIMENEZ F, et al. An artificial intelligence-enabled ECG algorithm for the identification of patients with atrial fibrillation during sinus rhythm：a retrospective analysis of outcome prediction[J]. Lancet，2019，394(10201):861-867. DOI：10.1016/S0140-6736(19)31721-0.
[13]	AL-ZAITI S, BESOMI L, BOUZID Z, et al. Machine learning-based prediction of acute coronary syndrome using only the pre-hospital 12-lead electrocardiogram[J]. Nat Commun，2020，11(1):3966. DOI：10.1038/s41467-020-17804-2.
[14]	SMITH S W, WALSH B, GRAUER K, et al. A deep neural network learning algorithm outperforms a conventional algorithm for emergency department electrocardiogram interpretation[J]. J Electrocardiol，2019，52:88-95. DOI：10.1016/j.jelectrocard.2018.11.013.
[15]	YAO X X, RUSHLOW D R, INSELMAN J W, et al. Artificial intelligence-enabled electrocardiograms for identification of patients with low ejection fraction：a pragmatic，randomized clinical trial[J]. Nat Med，2021，27(5):815-819. DOI：10.1038/s41591-021-01335-4.
[16]	SIONTIS K C, LIU K, BOS J M, et al. Detection of hypertrophic cardiomyopathy by an artificial intelligence electrocardiogram in children and adolescents[J]. Int J Cardiol，2021，340:42-47. DOI：10.1016/j.ijcard.2021.08.026.
[17]	LIU W T, LIN C S, TSAO T P, et al. A deep-learning algorithm-enhanced system integrating electrocardiograms and chest X-rays for diagnosing aortic dissection[J]. Can J Cardiol，2022，38(2):160-168. DOI：10.1016/j.cjca.2021.09.028.
[18]	TANG S Y, RAZEGHI O, KAPOOR R, et al. Machine learning-enabled multimodal fusion of intra-atrial and body surface signals in prediction of atrial fibrillation ablation outcomes[J]. Circ Arrhythm Electrophysiol，2022，15(8):e010850. DOI：10.1161/CIRCEP.122.010850.
[19]	RUSH B, CELI L A, STONE D J. Applying machine learning to continuously monitored physiological data[J]. J Clin Monit Comput，2019，33(5):887-893. DOI：10.1007/s10877-018-0219-z.
[20]	GUGLIN M E, THATAI D. Common errors in computer electrocardiogram interpretation[J]. Int J Cardiol，2006，106(2):232-237. DOI：10.1016/j.ijcard.2005.02.007.
[21]	SYED M, SYED S, SEXTON K, et al. Application of machine learning in intensive care unit（ICU）settings using MIMIC dataset：systematic review[J]. Informatics，2021，8(1):16. DOI：10.3390/informatics8010016.
[22]	MATAM B R, DUNCAN H, LOWE D. Machine learning based framework to predict cardiac arrests in a paediatric intensive care unit：prediction of cardiac arrests[J]. J Clin Monit Comput，2019，33(4):713-724. DOI：10.1007/s10877-018-0198-0.
[23]	FALSETTI L, RUCCO M, PROIETTI M, et al. Risk prediction of clinical adverse outcomes with machine learning in a cohort of critically ill patients with atrial fibrillation[J]. Sci Rep，2021，11(1):18925. DOI：10.1038/s41598-021-97218-2.
[24]	GUO Y T, WANG H, ZHANG H, et al. Mobile photoplethysmographic technology to detect atrial fibrillation[J]. J Am Coll Cardiol，2019，74(19):2365-2375. DOI：10.1016/j.jacc.2019.08.019.
[25]	SHAH A J, ISAKADZE N, LEVANTSEVYCH O, et al. Detecting heart failure using wearables：a pilot study[J]. Physiol Meas，2020，41(4):44001. DOI：10.1088/1361-6579/ab7f93.
[26]	HAIBE-KAINS B, ADAM G A, HOSNY A, et al. Transparency and reproducibility in artificial intelligence[J]. Nature，2020，586(7829):E14-16. DOI：10.1038/s41586-020-2766-y.
[27]	WYATT K D, POOLE L R, MULLAN A F, et al. Clinical evaluation and diagnostic yield following evaluation of abnormal pulse detected using Apple Watch[J]. J Am Med Inform Assoc，2020，27(9):1359-1363. DOI：10.1093/jamia/ocaa137.
[28]	TRAN V T, RIVEROS C, RAVAUD P. Patients' views of wearable devices and AI in healthcare：findings from the ComPaRe e-cohort[J]. NPJ Digit Med，2019，2:53. DOI：10.1038/s41746-019-0132-y.
[29]	PIRRACCHIO R, PETERSEN M L, CARONE M, et al. Mortality prediction in intensive care units with the Super ICU Learner Algorithm（SICULA）：a population-based study[J]. Lancet Respir Med，2015，3(1):42-52. DOI：10.1016/S2213-2600(14)70239-5.
[30]	WU T T, ZHENG R F, LIN Z Z, et al. A machine learning model to predict critical care outcomes in patient with chest pain visiting the emergency department[J]. BMC Emerg Med，2021，21(1):112. DOI：10.1186/s12873-021-00501-8.
[31]	ZHAO J, FENG Q P, WU P, et al. Learning from longitudinal data in electronic health record and genetic data to improve cardiovascular event prediction[J]. Sci Rep，2019，9(1):717. DOI：10.1038/s41598-018-36745-x.

《人工智能在心血管疾病中的应用科学声明》解读

Interpretation of the Use of Artificial Intelligence in Improving Outcomes in Heart Disease：a Scientific Statement from the American Heart Association

RichHTML

PDF

可视化

摘要/Abstract

引用本文

使用本文

参考文献 31

相关文章 15

编辑推荐

Metrics

留言

[1]	李婕, 丁虎. 脂蛋白a在心血管疾病中的研究新进展[J]. 中国全科医学, 2024, 27(36): 4505-4514.
[2]	张俊, 罗雯, 王绿娅, 杨娅, 陈彦. 综合医院血脂管理门诊模式建设探索与实践[J]. 中国全科医学, 2024, 27(36): 4527-4533.
[3]	王珍妮, 须月萍, 夏开建, 徐晓丹, 顾丽华. 基于YOLO神经网络构建压力性损伤自动检测和分期的人工智能模型[J]. 中国全科医学, 2024, 27(36): 4582-4590.
[4]	张龙, 李建平. 立足分级诊疗的血脂异常管控体系的建立与推广[J]. 中国全科医学, 2024, 27(36): 4493-4497.
[5]	吕垚, 刘力滴, 周伊恒, 贾禹, 杨梓钰, 陈华东, 廖晓阳, 沈灿, 雷弋. 美国心脏协会指南解读系列 ——《社区与心血管健康科学声明》解读[J]. 中国全科医学, 2024, 27(35): 4358-4363.
[6]	李一光, 刘荷君, 赵锦鹏, 冯焱, 徐银兰. 碳水化合物对心血管疾病风险因素影响的Meta分析[J]. 中国全科医学, 2024, 27(34): 4341-4349.
[7]	邵建文, 刘欢, 张玥, 郑爱明, 陈松宇, 王锦帆. 基于人工智能的医患沟通共情语言教学与评价系统的开发与应用研究[J]. 中国全科医学, 2024, 27(34): 4315-4321.
[8]	杨辉. 《全科医学服务中的人工智能：务实的、谨慎的、乐观的观点》摘译[J]. 中国全科医学, 2024, 27(32): 0-B.
[9]	刘环, 朱世飞, 陈法余, 王静华. 人工智能在基层全科医生实践中的应用：基于皮肤病诊断与病程管理的视角[J]. 中国全科医学, 2024, 27(31): 3884-3889.
[10]	刘忠典, 许琪, 陈伊静, 覃玲巧, 陈淑萍, 唐薇婷, 钟秋安. 心血管疾病中高风险人群颈动脉粥样硬化的识别：基于机器学习的预测模型及验证[J]. 中国全科医学, 2024, 27(30): 3763-3771.
[11]	张鹏, 刘力滴, 杨梓钰, 杨荣, 吕垚, 周伊恒, 方湘, 雷弋, 代华, 廖晓阳. 2023年美国预防临床服务指南工作组《妊娠期高血压疾病筛查》推荐声明解读[J]. 中国全科医学, 2024, 27(29): 3581-3586.
[12]	刘珏, 梁万年. 科技创新应对健康挑战[J]. 中国全科医学, 2024, 27(28): 0-C4.
[13]	郁海东, 潘苗苗, 顾红琴, 刘涛, 戴洁, 刘玲华, 侯俊平, 杨丽, 施美芳, 赵超. 社区老年人抑郁和认知状况与营养代谢的关联性研究[J]. 中国全科医学, 2024, 27(28): 3540-3545.
[14]	左仲琪, 王宇, 靳艳, 张庆伟, 袁彬彬, 沈赛娅, 王菲, 于漫. 心血管疾病风险早期预警评估工具的范围综述[J]. 中国全科医学, 2024, 27(27): 3440-3445.
[15]	钟旻珊, 孙伟, 孔祥清. 长新冠综合征对心血管系统的影响：临床表现、机制与诊治原则[J]. 中国全科医学, 2024, 27(27): 3325-3330.